The Biotech Growth Trust PLC (LON:BIOG)
London · Delayed Price · Currency is GBP · Price in GBX 1,604.00
+14.00 (0.88%)
Jul 16, 2026, 4:47 PM GMT
106.17% (1Y)
| Fund Assets | n/a |
| Expense Ratio | n/a |
| Min. Investment | n/a |
| Turnover | n/a |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Dividend Growth | n/a |
| Payout Frequency | n/a |
| Ex-Dividend Date | n/a |
| Previous Close | 1,590.00 |
| Volume | 54,715 |
| YTD Return | 33.67% |
| 1-Year Return | 106.17% |
| 52-Week Low | n/a |
| 52-Week High | n/a |
| Beta (5Y) | 0.29 |
| Holdings | n/a |
| Inception Date | n/a |
About BIOG
The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index. It was previously known as Finsbury Emerging Biotechnology Trust PLC. The Biotech Growth Trust PLC was formed on May 20, 1997 and is domiciled in the United Kingdom.
Country United Kingdom
Stock Exchange London Stock Exchange
Ticker Symbol BIOG